Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Sally Johnson

Newcastle AuthorsTitleYearFull text
Andrew Bryant
Jan Lecouturier
Giovany Orozco Leal
Dr Vicky Brocklebank
Dr Sonya Carnell
et al.		Eculizumab withdrawal and monitoring in atypical haemolytic uraemic syndrome (SETS aHUS): a multicentre, open label, prospective, single arm trial2025
Dr Sally Johnson
Proteolytic profiling of human plasma reveals an immunoactive complement C3 fragment2025
Laura Bailey
Vikki Bridgett
Dr Vicky Brocklebank
Dr Sally Johnson
Professor David Kavanagh
et al.		Quantifying association of early proteinuria and estimated glomerular filtration rate changes with long-term kidney failure in C3 glomerulopathy and immune-complex membranoproliferative glomerulonephritis using the United Kingdom RaDaR Registry2025
Giovany Orozco Leal
Professor Luke Vale
Dr Vicky Brocklebank
Andrew Bryant
Dr Thomas Chadwick
et al.		The cost-effectiveness of replacing lifelong therapy of eculizumab with a strategy of disease monitoring for eligible atypical haemolytic uraemic syndrome (aHUS) patients: an economic evaluation of the SETS aHUS trial2025
Dr Sally Johnson
Professor David Kavanagh
Professor John Sayer
Dr Edwin Wong
Megan Bates
et al.		Description and Cross-Sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort2024
Dr Sally Johnson
Dr Edwin Wong
Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work Group2024
Dr Sally Johnson
Professor David Kavanagh
Professor John Sayer
Dr Edwin Wong
Dr Vicky Brocklebank
Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort2024
Professor David Kavanagh
Dr Vicky Brocklebank
Dr Sally Johnson
Professor Neil Sheerin
Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum2024
Dr Edwin Wong
Lee-Ann Naidoo
Sarah Winn
Dr Patrick Walsh
Dr Vicky Brocklebank
et al.		The Annual Report of the National Renal Complement Therapeutics Centre 2022/232024
Emily Glover
Dr Kate Smith-Jackson
Dr Vicky Brocklebank
Dr Valerie Wilson
Dr Patrick Walsh
et al.		Assessing the Impact of Prophylactic Eculizumab on Renal Graft Survival in Atypical Hemolytic Uremic Syndrome2023
Dr Vicky Brocklebank
Dr Patrick Walsh
Dr Kate Smith-Jackson
Dr Thomas Hallam
Professor Kevin Marchbank
et al.		Atypical haemolytic uraemic syndrome in the era of terminal complement inhibition- An observational cohort study2023
Claire Marcroft
Professor Niina Kolehmainen
Professor Catherine Exley
Dr Richard Thomson
Dr Sally Johnson
et al.		Survey of current practice of routine neurodevelopmental follow-up in UK neonatal services2023
Dr Edwin Wong
Sarah Winn
Dr Michal Malina
Dr Sally Johnson
Professor Neil Sheerin
et al.		The Annual Report of the National Renal Complement Therapeutics Centre 2021/222023
Dr Tina Biss
Dr Paul Brennan
Philip Griffiths
Professor Rita Horvath
Professor Patrick Chinnery
et al.		GWAS meta-analysis of intrahepatic cholestasis of pregnancy implicates multiple hepatic genes and regulatory elements2022
Sarah Dunn
Abishek Umashankar
Andrew Bryant
Dr Sonya Carnell
Dr Thomas Chadwick
et al.		Saftey and impact of eculizumab withdrawal in patients with atypical haemolytic uraemic syndrome: protocol for a multicentre, open-label, prospective, single-arm study2022
123